Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
GLP-1 R 10 MG (Retatrutide) | For research use only
Retatrutide is a next-generation investigational peptide designed to target multiple pathways. It is a triple agonist, meaning it activates GLP-1 (glucagon-like peptide-1), GIP (glucose- dependent insulinotropic polypeptide) and glucagon receptors making it one of the most comprehensive peptide candidates in obesity, insulin resistance and metabolic research. This triple-receptor activation allows for synergistic effects on appetite regulation, blood sugar control, fat loss and energy expenditure.
Disclaimer:
All content and product information on this site is for educational and research purposes only. Our products are designed exclusively for in-vitro studies-experiments performed outside of the body. They are not medicines, have not been FDA-approved, and should never be used to diagnose, treat, or cure any condition. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
GLP-1 R 10 MG (Retatrutide) | For research use only
Retatrutide is a next-generation investigational peptide designed to target multiple pathways. It is a triple agonist, meaning it activates GLP-1 (glucagon-like peptide-1), GIP (glucose- dependent insulinotropic polypeptide) and glucagon receptors making it one of the most comprehensive peptide candidates in obesity, insulin resistance and metabolic research. This triple-receptor activation allows for synergistic effects on appetite regulation, blood sugar control, fat loss and energy expenditure.
Disclaimer:
All content and product information on this site is for educational and research purposes only. Our products are designed exclusively for in-vitro studies-experiments performed outside of the body. They are not medicines, have not been FDA-approved, and should never be used to diagnose, treat, or cure any condition. Bodily introduction of any kind into humans or animals is strictly forbidden by law.